|Articles|September 4, 2006
Antagonist or Agonist – Which to prefer? Video
OBGYN.net Conference Reportingfrom the 4th World Congress on Controversies in Obstetrics, Gynaecology and Infertility
Advertisement
The file you requested will begin playing automatically. If it does not, press the 'play' button. If you experience playback problems, make certain you have the latest version of Windows Media Player, available
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves tebipenem pivoxil as first oral carbapenem antibiotic for complicated urinary tract infections
2
Over half of elinzanetant's sleep benefit is VMS-independent
3
Stephanie Faubion, MD, MBA, on untangling sleep disorders from VMS in menopausal women
4
Fiona Baker, PhD, details elinzanetant's effectiveness on wakefulness after sleep onset in postmenopausal women
5